Abstract
Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.
| Translated title of the contribution | Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients |
|---|---|
| Original language | Danish |
| Article number | V07150610 |
| Journal | Ugeskrift for Laeger |
| Volume | 177 |
| Issue number | 50 |
| Pages (from-to) | 2-6 |
| Number of pages | 5 |
| ISSN | 0041-5782 |
| Publication status | Published - 7 Dec 2015 |